ARCHIVES

Decision to Cover New Colorectal Cancer Drugs, PET Scans.

This article is from The Cancer Letter archive.

Vol. 31 No. 05 | February 4, 2005

Download PDF Visit The Full Archive

Related Articles

Recompetitions Of DCT Contracts Okayed

March 3, 1989

National Action Plan: Return $14 Million To NCI, Committee Tells Shalala

February 14, 1997

Includes 8-page April 2002 Business & Regulatory Report.

May 3, 2002

Highlights of NCDDGs: 3 Drugs on Market, 12 in Development; Advisors Approve Plan to Issue $10.5 Million Contract For Pediatric Preclinical Testing Program

November 29, 2002

FDA Approves Taxotere And Gemzar; Sends Approvable Letter For Etopophos

May 24, 1996

NCCN’s First Physician CEO: Robert Carlson Pledges Broader Research and Policy Agenda

October 5, 2012